GenePortal for clinics
The genomic interpretation platform that accompanies every OmicaLabs report. Designed so your patients understand their results and you can focus on diagnosis.
Advantages for your practice
A report that evolves
New pathogenic variants described in ClinVar/HGMD automatically update the interpretation. No reanalysis request required.
Visual + actionable
Your patients see their results in context: ACMG pathogenicity, population frequency (gnomAD), inheritance, clinical advice.
Controlled access
Each patient accesses only their own report with private credentials. You, as the prescriber, can consult the cases from your centre.
More than 20 domains
ACMG SF v3.2 screening, pharmacogenetics (CPIC), PRS, nutrigenomics, cardiovascular risk, oncogenetics, reproductive health.
Patient support
Patients can raise queries from GenePortal. Our team of geneticists responds and, where appropriate, escalates the case to you.
Exportable
Download PDF report, annotated VCF or raw FASTQ/BAM data on request. Compatible with most EHRs.
What the clinical report includes
- Pathogenic / likely pathogenic variants in context (ACMG/AMP 2015)
- Variants of uncertain significance (VUS) with rationale
- Coverage and quality per gene
- Secondary findings ACMG SF v3.2 (opt-in)
- Pharmacogenetics: prescription of 60+ drugs per CPIC
- Polygenic risk scores (PRS): 26 phenotypes validated in European populations
- Reproductive carrier screening
Try it with a demo case
We provide access to an anonymised sample so you can navigate the platform before ordering your first test.